Clinical Studies

Search for a clinical study

 Indiana University School of Medicine offers hundreds of health studies right here in Indiana.

Search Results

57 results found

A Multicenter, Open-Label, Randomized, Bupivacaine-Controlled Study to Evaluate the Pharmacokinetics and Safety of EXPAREL for Postoperative Analgesia in Subjects Aged 0 to Less Than 6 ...

This Phase 1, multicenter, open-label, randomized, bupivacaine-controlled study is designed to evaluate the pharmacokinetics (PK) and safety of EXPAREL vs. bupivacaine HCl for postsurgical analgesia in pediatric subjects aged 0 ...

0 Years - 6 Years All Genders Enrolling By Invitation

Cleopattra: Effects of Nnc6019-0001 Versus Placebo on Cardiovascular Outcomes in Participants with Transthyretin Amyloid Cardiomyopathy

This study will find out if a new medicine called NNC6019-0001 can help reduce the risk of heart-related death and illness in participants with a condition called transthyretin amyloid cardiomyopathy ...

18 Years - 100 Years All Genders Enrolling By Invitation

Efficacy and Safety of Nnc0487-0111 Compared to Placebo on Morbidity and Mortality in People with Heart Failure with Preserved or Mildly Reduced Ejection Fraction ...

This study is being done to look at the safety and effect of NNC0487-0111 in people with Heart Failure with preserved Ejection Fraction (HFpEF) or Heart Failure with mildly reduced ...

18 Years - 100 Years All Genders Enrolling By Invitation

1011003020 1011003020 1011003020 Congenital Heart Surgeons' Society (CHSS) Studies in Congenital Heart Disease

The purpose of this study is to participate in a registry of patients with congenital heart disease. Patient data from the United States, Canada, and South America (whose institutions of ...

0 Years All Genders Enrolling By Invitation

50% and with Either a Wide QRS Complex (>130 Ms) or with/Anticipated >40% Pacing Randomized Clinical Trial

Cardiac-resynchronization therapy (CRT) is a type of heart failure (HF) treatment that improves the way your heart works, improves your ability to exercise, reduces hospitalization, and lengthens your lifespan. CRT ...

18 Years - 100 Years All Genders Enrolling By Invitation

1509977311 Pathogenetic Basis of Aortopathy and Aortic Valve Disease

The main purpose of this study is to define the complex genetic and pathogenic basis of thoracic aortic aneurysm (TAA) and other forms of aortopathy and/or aortic valve disease by ...

100 Years All Genders Enrolling By Invitation

1708709756 1708709756 1708709756 Genomic and Biomarker Studies in Pulmonary Hypertension

Pulmonary hypertension (PH) is an uncommon disease characterized by increased blood pressure in the pulmonary artery, which can lead to right heart failure and death. PH may be related to ...

100 Years All Genders Enrolling By Invitation

A Phase 2, Randomized, Multicenter, Open-Label, Blinded-Endpoint Study to Evaluate the Safety of Regn7508 and Regn9933, Monoclonal Antibodies Against Fxi, Versus Apixaban in Participants with ...

This study is researching experimental drugs called REGN7508 and REGN9933. The study is focused on participants who have atrial fibrillation, which means that the heart beats too fast and unevenly. ...

18 Years - 100 Years All Genders Enrolling By Invitation

Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Plozasiran in Adults with Severe Hypertriglyceridemia at High Risk of Acute Pancreatitis

This study will evaluate the efficacy and safety of plozasiran in approximately 140 adult participants with severe hypertriglyceridemia (SHTG) and history of at least two prior acute pancreatitis (AP) events ...

18 Years - 100 Years All Genders Enrolling By Invitation

A Phase 3, Double-Blind, Randomized, Placebo-Controlled Study of Levosimendan in Pulmonary Hypertension Patients with Heart Failure with Preserved Left Ventricular Ejection Fraction

The study will evaluate the efficacy and safety of chronic oral levosimendan compared with placebo in PH-HFpEF subjects. This subject population represents a large and growing group with no established ...

18 Years - 85 Years All Genders Enrolling By Invitation